(Q71917599)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Combined finasteride and flutamide therapy in men with advanced prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

D K Ornstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

G S Rao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

B Johnson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

E T Charlton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

G L Andriole

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

language of work or name

English

0 references

publication date

1 December 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

901-905

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Prostate cancer. Primary hormonal treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Patients' choice of treatment in stage D prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Antiandrogenic agents as monotherapy in advanced prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

1 reference

7 January 2021

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Treatment with finasteride following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Sequential androgen blockade: a biological study in the inhibition of prostatic growth

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Prognostic significance of prostate specific antigen in endocrine treatment for prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Prognostic significance of prostate-specific antigen in endocrine treatment for prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

Combination finasteride and flutamide in advanced carcinoma of the prostate: effective therapy with minimal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900315-9

7 January 2021

10.1016/S0090-4295(96)00315-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8973674%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference